Fatma Valiyeva

823 total citations
16 papers, 682 citations indexed

About

Fatma Valiyeva is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Fatma Valiyeva has authored 16 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Fatma Valiyeva's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and RNA Interference and Gene Delivery (4 papers). Fatma Valiyeva is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (5 papers) and RNA Interference and Gene Delivery (4 papers). Fatma Valiyeva collaborates with scholars based in Puerto Rico, United States and Canada. Fatma Valiyeva's co-authors include Pablo E. Vivas‐Mejía, Ileabett M. Echevarría-Vargas, Madeleine Moussa, Jim W. Xuan, Anil K. Sood, Ginette S. Santiago-Sánchez, Burton B. Yang, Joel Encarnación-Rosado, Glenn Bauman and Norman M. Greenberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Fatma Valiyeva

16 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fatma Valiyeva Puerto Rico	13	490	266	115	92	87	16	682
Lingxiong Wang China	14	296 0.6×	170 0.6×	151 1.3×	188 2.0×	95 1.1×	29	670
Chia‐Ing Jan Taiwan	14	305 0.6×	151 0.6×	116 1.0×	142 1.5×	134 1.5×	21	633
Vandana Iyer United States	14	445 0.9×	255 1.0×	229 2.0×	274 3.0×	48 0.6×	14	860
Xiaoxiang Rong China	14	473 1.0×	415 1.6×	140 1.2×	283 3.1×	50 0.6×	28	859
Guan Sun China	12	296 0.6×	246 0.9×	91 0.8×	134 1.5×	53 0.6×	16	565
Stefan Eser Germany	11	427 0.9×	127 0.5×	55 0.5×	298 3.2×	78 0.9×	18	715
Manuela Sciro Italy	7	341 0.7×	147 0.6×	26 0.2×	94 1.0×	51 0.6×	9	506
Jean‐Baptiste Oudart France	11	243 0.5×	171 0.6×	74 0.6×	197 2.1×	51 0.6×	32	578
Katharine L. Sodek Canada	10	279 0.6×	134 0.5×	46 0.4×	265 2.9×	118 1.4×	10	659
Minna Niemelä Finland	3	474 1.0×	88 0.3×	51 0.4×	242 2.6×	39 0.4×	3	702

Countries citing papers authored by Fatma Valiyeva

Since Specialization

Citations

This map shows the geographic impact of Fatma Valiyeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Valiyeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Valiyeva more than expected).

Fields of papers citing papers by Fatma Valiyeva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma Valiyeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Valiyeva. The network helps show where Fatma Valiyeva may publish in the future.

Co-authorship network of co-authors of Fatma Valiyeva

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma Valiyeva. A scholar is included among the top collaborators of Fatma Valiyeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma Valiyeva. Fatma Valiyeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Santiago-Sánchez, Ginette S., Eliud Hernandez O'Farril, Fatma Valiyeva, et al.. (2021). Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. International Journal of Molecular Sciences. 22(16). 8581–8581. 15 indexed citations

Valiyeva, Fatma, et al.. (2020). Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma. SHILAP Revista de lepidopterología. 1 indexed citations

Santiago-Sánchez, Ginette S., et al.. (2020). <p>Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma</p>. International Journal of Nanomedicine. Volume 15. 2809–2828. 91 indexed citations

Valiyeva, Fatma, et al.. (2020). MicroRNA-18a-5p Suppresses Tumor Growth via Targeting Matrix Metalloproteinase-3 in Cisplatin-Resistant Ovarian Cancer. Frontiers in Oncology. 10. 602670–602670. 22 indexed citations

Valiyeva, Fatma, et al.. (2019). MicroRNA‐92b is a potential therapeutic target for Glioblastoma treatment. The FASEB Journal. 33(S1). 1 indexed citations

Valiyeva, Fatma, et al.. (2018). Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression. Cancers. 10(10). 382–382. 22 indexed citations

Valiyeva, Fatma, et al.. (2017). Abstract 88: The role of RBPMS in cisplatin resistant ovarian cancer. Cancer Research. 77(13_Supplement). 88–88. 1 indexed citations

Valiyeva, Fatma, et al.. (2016). Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells. Oncotarget. 7(24). 36321–36337. 87 indexed citations

Armaiz-Peña, Guillermo N., Lingegowda S. Mangala, Fatma Valiyeva, et al.. (2015). Targeting c-MYC in Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 14(10). 2260–2269. 94 indexed citations

10.

Echevarría-Vargas, Ileabett M., Fatma Valiyeva, & Pablo E. Vivas‐Mejía. (2014). Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway. PLoS ONE. 9(5). e97094–e97094. 103 indexed citations

11.

Li, Jia, Jim W. Xuan, Fatma Valiyeva, et al.. (2014). SKA1 over‐expression promotes centriole over‐duplication, centrosome amplification and prostate tumourigenesis. The Journal of Pathology. 234(2). 178–189. 38 indexed citations

12.

Valiyeva, Fatma, Paul S. Rennie, Wei‐Yang Lu, et al.. (2012). TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis. BMJ Open. 2(5). e001410–e001410. 40 indexed citations

13.

Vivas‐Mejía, Pablo E., Cristian Rodriguez‐Aguayo, Hee‐Dong Han, et al.. (2011). Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer. Clinical Cancer Research. 17(11). 3716–3726. 58 indexed citations

14.

Valiyeva, Fatma, Fei Jiang, Madeleine Moussa, et al.. (2011). Characterization of the Oncogenic Activity of the Novel TRIM59 Gene in Mouse Cancer Models. Molecular Cancer Therapeutics. 10(7). 1229–1240. 40 indexed citations

15.

Xuan, Jim W., Fatma Valiyeva, Madeleine Moussa, et al.. (2009). Molecular Targeted Enhanced Ultrasound Imaging of Flk1 Reveals Diagnosis and Prognosis Potential in a Genetically Engineered Mouse Prostate Cancer Model. Molecular Imaging. 8(4). 209–20. 19 indexed citations

16.

Xuan, Jim W., Hongyi Jiang, Fatma Valiyeva, et al.. (2007). Functional Neoangiogenesis Imaging of Genetically Engineered Mouse Prostate Cancer Using Three-Dimensional Power Doppler Ultrasound. Cancer Research. 67(6). 2830–2839. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact